1. Home
  2. KROS vs DXYZ Comparison

KROS vs DXYZ Comparison

Compare KROS & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$20.36

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Logo Destiny Tech100 Inc.

DXYZ

Destiny Tech100 Inc.

HOLD

Current Price

$30.51

Market Cap

447.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KROS
DXYZ
Founded
2015
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
655.9M
447.0M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
KROS
DXYZ
Price
$20.36
$30.51
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$22.20
N/A
AVG Volume (30 Days)
742.6K
N/A
Earning Date
11-05-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.57
N/A
Revenue
$246,718,000.00
N/A
Revenue This Year
$6,924.79
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.87
N/A
Revenue Growth
37798.31
N/A
52 Week Low
$9.12
N/A
52 Week High
$22.55
N/A

Technical Indicators

Market Signals
Indicator
KROS
DXYZ
Relative Strength Index (RSI) 54.81 53.49
Support Level $19.76 $30.10
Resistance Level $21.76 $32.98
Average True Range (ATR) 0.68 3.12
MACD -0.24 -0.26
Stochastic Oscillator 28.09 15.51

Price Performance

Historical Comparison
KROS
DXYZ

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About DXYZ Destiny Tech100 Inc.

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Share on Social Networks: